News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 31, 2007

Oct 31, 2007

GAO critiques anthrax vaccine procurement, management

(CIDRAP News) – The US government's attempt to add a next-generation anthrax vaccine to its stockpile failed because of a premature contract award, unrealistic expectations, and confusion about how the vaccine would be used, according to the Government Accountability Office (GAO), the investigative agency of Congress.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jun 27, 2007

Jun 27, 2007

GAO assesses avian and pandemic flu planning

(CIDRAP News) – The Government Accountability Office (GAO) issued two reports that address avian and pandemic influenza planning last week, one examining how well the US Department of Agriculture (USDA) is prepared to respond to avian flu outbreaks and the other assessing efforts by US and international agencies to help vulnerable countries.

May 30, 2007

May 30, 2007

VaxGen stops work on anthrax vaccine, seeks partner

(CIDRAP News) – VaxGen Inc., which lost an $877.5 million contract with the US government for a new anthrax vaccine in December, announced May 24 it was stopping development of the vaccine and said it hopes to license the product to another company.

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»